Schedule 13D ownership disclosure

IN8BIO INC

Common Stock, par value $0.0001 per share · CUSIP: 45674E109

Event date: 2025-05-02

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • BIOS FUND II, LPReported CIK 0001714576

    Shares: 574,432.00 · Class: 0.6%

  • BIOS FUND II QP, LPReported CIK 0001716869

    Shares: 1,876,624.00 · Class: 2.1%

  • BIOS FUND II NT, LPReported CIK 0001728851

    Shares: 251,211.00 · Class: 0.3%

  • BIOS INCYSUS CO-INVEST I, LPReported CIK 0001740029

    Shares: 997,433.00 · Class: 1.1%

  • BIOS FUND III, LPReported CIK 0001791917

    Shares: 570,724.00 · Class: 0.6%

  • BIOS FUND III QP, LPReported CIK 0001791916

    Shares: 3,727,597.00 · Class: 4.1%

  • BIOS FUND III NT, LPReported CIK 0001791910

    Shares: 601,980.00 · Class: 0.7%

  • BIOS CLINICAL OPPORTUNITY FUND, LPReported CIK 0001988639

    Shares: 3,140,803.00 · Class: 3.3%

  • BP DIRECTORS, LPReported CIK 0001813311

    Shares: 121,775.00 · Class: 0.1%

  • BIOS EQUITY PARTNERS, LPReported CIK 0001813314

    Shares: 121,775.00 · Class: 0.1%

  • BIOS EQUITY PARTNERS II, LPReported CIK 0001813313

    Shares: 3,699,700.00 · Class: 4.1%

  • BIOS EQUITY PARTNERS III, LPReported CIK 0001831976

    Shares: 4,900,301.00 · Class: 5.4%

  • BIOS EQUITY COF, LPReported CIK 0002000747

    Shares: 3,140,803.00 · Class: 3.3%

  • CAVU MANAGEMENT, LPReported CIK 0001813270

    Shares: 8,721,776.00 · Class: 9.6%

  • BIOS CAPITAL MANAGEMENT, LPReported CIK 0001813845

    Shares: 9,120,073.00 · Class: 9.99%

  • CAVU ADVISORS, LLCReported CIK 0001813310

    Shares: 8,721,776.00 · Class: 9.6%

  • BIOS ADVISORS GP, LLCReported CIK 0001813844

    Shares: 9,120,073.00 · Class: 9.9%

  • LESLIE W. KREISReported CIK 0001813316

    Shares: 8,721,776.00 · Class: 9.6%

  • AARON G.L. FLETCHERReported CIK 0001789490

    Shares: 9,120,073.00 · Class: 9.99%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-25-046280
Form type
SCHEDULE 13D/A
Filer
BIOS Fund II, LP
CIK
CIK 1714576
Filed
May 08, 2025
Reporting period
May 02, 2025
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub